Ameriprise’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-42,221
| Closed | -$13.4M | – | 3999 |
|
2023
Q4 | $13.4M | Buy |
42,221
+8,068
| +24% | +$2.55M | ﹤0.01% | 1544 |
|
2023
Q3 | $5.77M | Buy |
34,153
+31,787
| +1,343% | +$5.37M | ﹤0.01% | 2174 |
|
2023
Q2 | $513K | Buy |
2,366
+259
| +12% | +$56.2K | ﹤0.01% | 3420 |
|
2023
Q1 | $383K | Buy |
2,107
+79
| +4% | +$14.4K | ﹤0.01% | 3525 |
|
2022
Q4 | $398K | Sell |
2,028
-65
| -3% | -$12.8K | ﹤0.01% | 3488 |
|
2022
Q3 | $471K | Sell |
2,093
-163
| -7% | -$36.7K | ﹤0.01% | 3412 |
|
2022
Q2 | $285K | Buy |
2,256
+667
| +42% | +$84.3K | ﹤0.01% | 3578 |
|
2022
Q1 | $201K | Sell |
1,589
-744
| -32% | -$94.1K | ﹤0.01% | 3754 |
|
2021
Q4 | $306K | Sell |
2,333
-7
| -0.3% | -$918 | ﹤0.01% | 3662 |
|
2021
Q3 | $286K | Buy |
2,340
+26
| +1% | +$3.18K | ﹤0.01% | 3590 |
|
2021
Q2 | $264K | Buy |
2,314
+178
| +8% | +$20.3K | ﹤0.01% | 3684 |
|
2021
Q1 | $257K | Buy |
2,136
+39
| +2% | +$4.69K | ﹤0.01% | 3639 |
|
2020
Q4 | $213K | Buy |
+2,097
| New | +$213K | ﹤0.01% | 3603 |
|